Shiv Kumar Sarin is an Indian physician; an outstanding hepatologist (Liver specialist), gastroenterologist, translational scientist, accomplished researcher, mentor, and a gifted teacher.
Under the aegis of Delhi Govt., he set-up the Institute of Liver and Biliary Sciences (ILBS); the largest liver hospital and a deemed Liver University, and a WHO Centre.
He is a prolific researcher with an H-index of 113.
1998
He championed to generate public awareness on Hepatitis B, by organizing “Yellow Ribbon Campaign” since 1998, observed as Hepatitis Awareness Day by GNCTD for 25 years.
2001
He initiated and guided the launch of the first Universal Hepatitis B vaccination program for newborns in India in Delhi, in 2001.
2002
Launch of pilot National Hepatitis B Vaccination program by Shri Atal Bihari Vajpayee (2002). In 2013, he also initiated the “Healthy Liver-Healthy India”, a campaign to focus on liver health.
2007
He has received Shanti Swarup Bhatnagar Prize, The World Academy of Science Prize, and Padma Bhushan in 2007.
He served as Chairman Board of Governors of Medical Council of India and shaped the New Medical Education Vision, including NEET and NEXT exams.
He is a leader in science and served as the President of the Asian Pacific Association for study of Liver and is currently the President of the National Academy of Medical Sciences (NAMS) of India (2021-2024).
Prof. Shiv Kumar Sarin, Chancellor, Institute of Liver and Biliary Sciences, is an astute clinician, a liver specialist, a front-line researcher, a gifted teacher and a public health champion.
He is a visionary and established the Institute of Liver and Biliary Sciences (ILBS) under Delhi Govt., a Liver University, with most advanced hospital with therapeutic, academic and research outputs in liver diseases.
Dr. Sarin is a leader in science and is currently the President of the National Academy of Medical Sciences (India).
He is also serving as an Adjunct Faculty of Molecular Medicine at Jawaharlal Nehru University, Delhi.
With 7 gold medals in M.B.B.S. and one in L.L.B (law), he continued academic excellence by being a Fogarty Fellow, Japanese SPH Fellow, and Fellow of all science academies in India.
His research has enriched the discipline of Liver Diseases [with nearly 800 publications, with an H-index of 113, and more than 65,000 citations].
His seminal work on band ligation for prevention of variceal bleeding in The NEJM and Sarin’s Classification of Gastric Varices are universally accepted.
He described two new disease entities; Acute-on-Chronic Liver Failure and Portal biliopathy.
He is credited globally to give a large number of new protocols for the management of liver disease patients.
His use of growth factors to stimulate bone marrow for liver regeneration as an alternative to liver transplant opened new treatment vistas.
He pioneered fecal microbiota transplantation for alcoholic hepatitis.
He is the founder Chief-editor of Hepatology International, a Springer Nature publication.
2012
Dr. Sarin was able to set-up the Asian Pacific School of Hepatology at ILBS since 2012.
Policy Initiatives:
2015
As Chairman of Board of Governors of Medical Council of India (MCI), he introduced seminal reforms in medical education, and scripted ‘Vision 2015’ of Medical Education in India.
The ‘National Eligibility cum Entrance Test (NEET)’ and common exit examination (now called NEXT) were his brainchild and are serving well the country.
He chaired policy initiatives for Integrating Ayurveda and Modern System of Medicine at Niti Aayog.
He helped and led the GoI in 2021 into Integration of Non-Alcoholic Fatty Liver Disease (NAFLD) within the ambit of NCDs, making India the first country globally (covered by the Lancet, applauded by DG, WHO).
2018
He was instrumental in development of “National Viral Hepatitis Control Program”, implemented by the GoI in 2018.
He helped set-up the National Liver Disease Bio-bank with the help of DBT.
Community service:
Dr. Sarin launched “Empathy” (Empowering People Against Hepatitis), a program to give equal rights to more than 50 million people living with hepatitis [2018].
Initiated HepiSchool (Hepatitis Initiated School) program [2018-19] for Delhi Govt.
schools for protection of children from hepatitis.
His “Liv Healthy” mission is core to major health programs [2018] and runs mobile Liver Vans in Delhi.
Started SMiLES (Stronger India through a Million Health Educated Students) project for young and healthy India.
Set-up the First Plasma Bank in India for Covid patients at ILBS under the GNCTD.
This 24x7 bank, served and issued more than 8,000 plasma units.
Dr. Sarin is a Senior Professor of Hepatology and Chancellor of ILBS University.
He set-up a WHO collaborative center on liver diseases at ILBS and is its Director.
2020
In 2020-2023 parliamentarians at the Sansad, pledged to eliminate hepatitis B and C from India.
